CoChat
Sign Up
Cited by 7983D Printing in Biomedical ResearchCancer Cells and MetastasisAnimal testing and alternatives

The DOI matches its Crossref record; 155 of the 163 references it cites were found in a registry or an index.

The use of 3-d cultures for high-throughput screening: the multicellular spheroid model.

Open access
Kunz-Schughart, Leoni A., Freyer, James P., Hofstaedter, Ferdinand, Ebner, Reinhard·2004·SLAS DISCOVERY
DOI 10.1177/1087057104265040
Open this paper in CoChat — free accountOpen PDF

Abstract

Over the past few years, establishment and adaptation of cell-based assays for drug development and testing has become an important topic in high-throughput screening (HTS). Most new assays are designed to rapidly detect specific cellular effects reflecting action at various targets. However, although more complex than cell-free biochemical test systems, HTS assays using monolayer or suspension cultures still reflect a highly artificial cellular environment and may thus have limited predictive value for the clinical efficacy of a compound. Today's strategies for drug discovery and development, be they hypothesis free or mechanism based, require facile, HTS-amenable test systems that mimic the human tissue environment with increasing accuracy in order to optimize preclinical and preanimal selection of the most active molecules from a large pool of potential effectors, for example, against solid tumors. Indeed, it is recognized that 3-dimensional cell culture systems better reflect the in vivo behavior of most cell types. However, these 3-D test systems have not yet been incorporated into mainstream drug development operations. This article addresses the relevance and potential of 3-D in vitro systems for drug development, with a focus on screening for novel antitumor drugs. Examples of 3-D cell models used in cancer research are given, and the advantages and limitations of these systems of intermediate complexity are discussed in comparison with both 2-D culture and in vivo models. The most commonly used 3-D cell culture systems, multicellular spheroids, are emphasized due to their advantages and potential for rapid development as HTS systems. Thus, multicellular tumor spheroids are an ideal basis for the next step in creating HTS assays, which are predictive of in vivo antitumor efficacy.

Overview

Integrity signals

Registry

Crossref · 10.1177/1087057104265040

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 163 references

Research works printed but not linked: 4

  1. Muralidhar, 2001, Development of high-density cultivation systems by bioencapsulation, Curr Sci, 81, 263
  2. Ochs, 2003, Evidence for the isolation, growth, and characterization of malignant cells in primary cultures of human tumors, In Vitro Cell Dev Biol Anim, 39, 63, 10.1290/1543-706X(2003)039<0063:EFTIGA>2.0.CO;2 · DOI
  3. Gottwald, 2002, Gewebezüchtung. Hilfsarbeiter für die Leber, Spektrum der Wissenschaft, 1, 44
  4. Düchting, 1995, Modeling of radiogenic responses induced by fractionated irradiation in malignant and normal tissue, Stem Cells, 13, 301

Cited by

Sorted by citations

Items 401–500 of 798

Related

See all

Metadata

Authors
Kunz-Schughart, L. A., Freyer, J. P., Hofstaedter, F., & Ebner, R.
Affiliations
  • Los Alamos National Laboratory (US)
  • University of Regensburg (DE)
  • Avalon Pharma (United States) (US)
Venue
SLAS DISCOVERY
Publisher
Elsevier BV
Published
2004-06
Volume
9
Issue
4
Pages
273-285
ISSN
2472-5552 (ISSN-L)
DOI
10.1177/1087057104265040
OpenAlex
W2140723257
Cited by
797
References
163
Citations by year
2026: 21 · 2025: 26 · 2024: 24 · 2023: 29 · 2022: 38 · 2021: 38 · 2020: 45 · 2019: 39 · 2018: 51 · 2017: 61 · 2016: 63 · 2015: 50 · 2014: 46 · 2013: 58 · 2012: 29
FWCI
11.64
Type
journal article
Language
en
Open access
Licence
Locations
  • SLAS DISCOVERY (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Keywords
tumor spheroids, 3D cell culture, high-throughput screening, anticancer drug screening, drug development, solid tumors, cell-based assays
MeSH terms
Animals, Antineoplastic Agents, Drug Evaluation, Preclinical, Drug Screening Assays, Antitumor, Humans, Models, Biological, Tumor Cells, Cultured, Spheroids, Cellular, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review